Kiwi health care supplies company EBOS is in front of fund managers seeking a $NZ150 million equity injection.
Stockbroker UBS launched the dual-listed company's equity raising on Tuesday morning, calling for bids at $NZ19.70 a share which was an 8 per cent discount to the last close.
Loading...
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Anthony Macdonald is a Chanticleer columnist. He is a former Street Talk co-editor and has 10 years' experience as a business journalist and worked at PwC, auditing and advising financial services companies. Connect with Anthony on Twitter. Email Anthony at a.macdonald@afr.com
